Skip to Main Content

Paper Details

Comparative Survival Associated With Use of Targeted vs Nontargeted Therapy in Medicare Patients With Metastatic Renal Cell Carcinoma.
JAMA Netw Open
12
2019
Author NameAffiliation
Jalpa A DoshiPerelman School of Medicine, University of Pennsylvania
Jalpa A DoshiLeonard Davis Institute of Health Economics, University of Pennsylvania
Jalpa A DoshiCenter for Public Health Initiatives, University of Pennsylvania
  • 1 - 3

Datasets

Release 1.2